Location: Stockholm, Sweden
CIK: 0001599882 · Show all filings
Period: Q3 2014 (← Previous) (Next →)
Filing Date: Nov 3, 2014
Total Value: $342M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Johnson & Johnson | 140,000 | $14.92M | 4.4% | — | — | Call | 478160904 |
| ALKS | Alkermes Plc | 266,000 | $11.4M | 3.3% | $41.72 | +7.4% | SHS | G01767105 |
| UHS | Universal Health Services Inc B | 98,700 | $10.31M | 3.0% | $94.47 | +7.3% | COM | 913903100 |
| — | Alexion Pharmaceuticals Inc | 58,000 | $9.618M | 2.8% | $143.60 | — | COM | 015351109 |
| BIIB | Biogen IDEC Inc | 29,000 | $9.593M | 2.8% | $282.74 | +16.6% | COM | 09062X103 |
| — | Salix Pharmaceutical Ltd | 54,000 | $8.437M | 2.5% | $102.84 | — | COM | 795435106 |
| GILD | Gilead Sciences Inc | 72,000 | $7.664M | 2.2% | $51.81 | +31.3% | COM | 375558103 |
| — | Celgene Corp | 80,000 | $7.582M | 2.2% | $115.06 | — | COM | 151020104 |
| — | Medtronic Inc | 133,800 | $6.867M | 2.0% | $51.32 | — | COM | 585055106 |
| BMRN | BioMarin Pharmaceutical Inc | 92,000 | $6.639M | 1.9% | $69.41 | -5.3% | COM | 09061G101 |
| — | Covidien Plc | 76,000 | $6.575M | 1.9% | $84.47 | — | SHS | G2554F113 |
| ABBV | AbbVie Inc | 111,000 | $6.411M | 1.9% | $35.17 | 0.0% | COM | 00287Y109 |
| — | Nektar Therapeutics | 508,000 | $6.132M | 1.8% | $11.93 | — | COM | 640268108 |
| TMO | Thermo Fisher Scientific Inc | 49,000 | $5.963M | 1.7% | $106.18 | +10.5% | COM | 883556102 |
| — | NPS Pharmaceuticals Inc | 224,000 | $5.824M | 1.7% | $27.30 | — | COM | 62936P103 |
| CVS | CVS Health Corp | 72,000 | $5.73M | 1.7% | $49.72 | +15.6% | COM | 126650100 |
| ACAD | Acadia Pharmaceuticals Inc | 219,000 | $5.422M | 1.6% | $23.65 | -1.1% | COM | 004225108 |
| — | Rite Aid Corp | 1,118,000 | $5.411M | 1.6% | $5.17 | — | COM | 767754104 |
| INCY | Incyte Corp Ltd | 107,000 | $5.248M | 1.5% | $48.06 | +4.3% | COM | 45337C102 |
| BMY | Bristol Myers Squibb Co | 99,000 | $5.067M | 1.5% | $34.43 | -0.6% | COM | 110122108 |
| VRTX | Vertex Pharmaceuticals Inc | 43,000 | $4.829M | 1.4% | $70.12 | +35.8% | COM | 92532F100 |
| — | Actavis Plc | 20,000 | $4.826M | 1.4% | $223.04 | — | SHS | G0083B108 |
| REGN | Regeneron Pharmaceuticals Inc | 13,000 | $4.598M | 1.3% | $292.89 | +13.8% | COM | 75886F107 |
| — | Pharmacyclics Inc | 38,000 | $4.462M | 1.3% | $103.65 | — | COM | 716933106 |
| CAH | Cardinal Health Inc | 59,000 | $4.42M | 1.3% | $49.64 | +7.4% | COM | 14149Y108 |
| — | Intercept Pharmaceuticals Inc | 18,600 | $4.402M | 1.3% | $236.67 | — | COM | 45845P108 |
| CYH | Community Health Syst Inc | 79,000 | $4.328M | 1.3% | $33.69 | +23.4% | COM | 203668108 |
| MCK | McKesson Corp | 22,000 | $4.283M | 1.3% | $151.16 | +17.0% | COM | 58155Q103 |
| DXCM | Dexcom Inc | 106,000 | $4.239M | 1.2% | $8.27 | +23.5% | COM | 252131107 |
| — | WellPoint Inc | 35,000 | $4.186M | 1.2% | $91.56 | — | COM | 94973V107 |
| HCA | HCA Holdings Inc | 58,000 | $4.09M | 1.2% | $43.68 | +40.7% | COM | 40412C101 |
| — | Catamaran Corp | 93,000 | $3.92M | 1.1% | $44.11 | — | COM | 148887102 |
| COR | AmerisourceBergen Corp | 50,000 | $3.865M | 1.1% | $51.53 | +7.7% | COM | 03073E105 |
| MRK | Merck Co Inc | 65,000 | $3.853M | 1.1% | $31.40 | +25.4% | COM | 58933Y105 |
| — | Medivation Inc | 38,000 | $3.757M | 1.1% | $64.37 | — | COM | 58501N101 |
| — | Thoratec Corp | 133,800 | $3.576M | 1.0% | $31.71 | — | COM | 885175307 |
| — | St Jude Medical Inc | 57,000 | $3.427M | 1.0% | $62.12 | — | COM | 790849103 |
| AMGN | Amgen Inc | 23,000 | $3.231M | 0.9% | $89.55 | +5.6% | COM | 031162100 |
| TEVA | Teva Pharma Ind Ltd ADR repr 1 Share | 59,000 | $3.171M | 0.9% | $50.11 | — | COM | 881624209 |
| UNH | United Health Group Inc | 35,000 | $3.019M | 0.9% | $60.89 | +15.5% | COM | 91324P102 |
| — | Abiomed Inc | 120,736 | $2.998M | 0.9% | $26.15 | — | COM | 003654100 |
| — | Allergan Inc | 16,500 | $2.94M | 0.9% | $130.05 | — | COM | 018490102 |
| MASI | Masimo Corp | 135,000 | $2.873M | 0.8% | $25.86 | -11.7% | COM | 574795100 |
| — | Aetna Inc | 35,000 | $2.835M | 0.8% | $81.03 | — | COM | 00817Y108 |
| — | Allscripts Healthcare So Inc | 210,000 | $2.817M | 0.8% | $13.41 | — | COM | 01988PAD0 |
| — | Express Scripts Hg Co | 39,000 | $2.755M | 0.8% | $70.54 | — | COM | 30219G108 |
| — | Celladon Corp | 256,556 | $2.684M | 0.8% | $11.46 | — | COM | 15117E107 |
| — | Clovis Oncology Inc | 57,000 | $2.586M | 0.8% | $41.41 | — | COM | 189464100 |
| BSX | Boston Scientific Corp | 214,000 | $2.527M | 0.7% | $12.22 | +3.1% | COM | 101137107 |
| CNC | Centene Corp | 30,000 | $2.481M | 0.7% | $15.09 | +27.8% | COM | 15135B101 |
| — | CR Bard Inc | 17,000 | $2.426M | 0.7% | $142.97 | — | COM | 067383109 |
| MD | Mednax Inc | 44,000 | $2.412M | 0.7% | $58.17 | -2.5% | COM | 58502B106 |
| — | Cerner Corp | 40,000 | $2.383M | 0.7% | $52.57 | — | COM | 156782104 |
| PODD | Insulet Corp | 62,911 | $2.318M | 0.7% | $37.55 | -2.8% | COM | 45784P101 |
| — | Ariad Pharmaceuticals Inc | 423,000 | $2.284M | 0.7% | $6.55 | — | COM | 04033A100 |
| — | Isis Pharmaceuticals Inc | 58,000 | $2.252M | 0.7% | $36.11 | — | COM | 464330109 |
| — | Cyberonics Inc | 43,000 | $2.2M | 0.6% | $65.00 | — | COM | 23251P102 |
| HOLX | Hologic Inc | 90,000 | $2.19M | 0.6% | $23.72 | +6.4% | COM | 436440101 |
| — | Aegerion Pharmaceuticals Inc | 65,000 | $2.17M | 0.6% | $57.62 | — | COM | 00767E102 |
| — | Parexel Intl Corp | 34,000 | $2.145M | 0.6% | $45.99 | — | COM | 699462107 |
| — | Endologix Inc | 200,000 | $2.12M | 0.6% | $14.71 | — | COM | 29266S106 |
| — | Amsurg Corp | 42,300 | $2.117M | 0.6% | $47.16 | — | COM | 03232P405 |
| — | Orexigen Therapeutics Inc | 494,000 | $2.104M | 0.6% | $5.22 | — | COM | 686164104 |
| EW | Edwards Lifesciences Corp | 20,000 | $2.043M | 0.6% | $11.54 | +36.8% | COM | 28176E108 |
| — | Intra-Cellular Therapies Inc | 149,000 | $2.043M | 0.6% | $16.66 | — | COM | 46116X101 |
| — | CareFusion Corp | 45,000 | $2.036M | 0.6% | $41.11 | — | COM | 14170T101 |
| — | Revance Therapeutics Inc | 105,255 | $2.035M | 0.6% | $29.60 | — | COM | 761330109 |
| ESPR | Esperion Therapeutics Inc | 82,921 | $2.028M | 0.6% | $15.89 | 0.0% | COM | 29664W105 |
| — | Hyperion Therapeutics Inc | 80,369 | $2.027M | 0.6% | $20.84 | — | COM | 44915N101 |
| — | Achillion Pharmaceuticals Inc | 200,000 | $1.996M | 0.6% | $7.57 | — | COM | 00448Q201 |
| — | Cigna Corp | 22,000 | $1.995M | 0.6% | $86.45 | — | COM | 125509109 |
| INFIQ | Infinity Pharm Inc | 148,000 | $1.986M | 0.6% | $13.60 | -12.5% | COM | 45665G303 |
| — | Cepheid Inc | 45,000 | $1.981M | 0.6% | $47.03 | — | COM | 15670R107 |
| LLY | Eli Lilly & Co | 30,000 | $1.946M | 0.6% | $41.29 | +24.4% | COM | 532457108 |
| — | ImmunoGen Inc | 180,000 | $1.906M | 0.6% | $12.44 | — | COM | 45253H101 |
| — | NuVasive Inc | 54,000 | $1.883M | 0.6% | $38.41 | — | COM | 670704105 |
| — | Keryx Biopharmaceuticals Inc | 136,000 | $1.87M | 0.5% | $12.95 | — | COM | 492515101 |
| AFL | Aflac Inc | 32,000 | $1.864M | 0.5% | $23.68 | -1.9% | COM | 001055102 |
| SUPN | Supernus Pharmaceuticals Inc | 212,000 | $1.842M | 0.5% | $7.25 | +24.6% | COM | 868459108 |
| LGND | Ligand Pharmaceuticals Inc B | 39,000 | $1.833M | 0.5% | $33.38 | -0.6% | COM | 53220K504 |
| — | Celldex Therapeutics Inc | 138,000 | $1.788M | 0.5% | $19.24 | — | COM | 15117B103 |
| MGNX | Macrogenics Inc | 85,000 | $1.777M | 0.5% | $24.28 | -14.8% | COM | 556099109 |
| — | Dynavax Technologies Corp | 1,228,354 | $1.757M | 0.5% | $1.96 | — | COM | 268158102 |
| SYK | Stryker Corp | 21,000 | $1.696M | 0.5% | $69.86 | +3.0% | COM | 863667101 |
| JAZZ | Jazz Pharmaceuticals Plc | 10,000 | $1.606M | 0.5% | $153.75 | 0.0% | SHS | G50871105 |
| — | Tesaro Inc | 55,000 | $1.481M | 0.4% | $31.11 | — | COM | 881569107 |
| — | Sunesis Pharmaceuticals Inc | 201,171 | $1.436M | 0.4% | $6.58 | — | COM | 867328601 |
| — | Array BioPharma Inc | 379,199 | $1.354M | 0.4% | $4.82 | — | COM | 04269X105 |
| — | Auxilium Pharmaceuticals Inc | 44,953 | $1.342M | 0.4% | $29.85 | — | COM | 05334DAA5 |
| ALNY | Alnylam Pharmaceuticals Inc | 13,030 | $1.018M | 0.3% | $64.51 | 0.0% | COM | 02043Q107 |
| — | BIND Therapeutics Inc | 108,535 | $932K | 0.3% | $12.51 | — | COM | 05548N107 |
| — | Anthera Pharmaceuticals Inc | 400,000 | $768K | 0.2% | $2.93 | — | COM | 03674U201 |
| EXEL | Exelixis Inc | 500,000 | $765K | 0.2% | $4.57 | -29.7% | COM | 30161Q104 |
| — | Omnicare Inc | 10,000 | $623K | 0.2% | $60.31 | — | COM | 681904108 |
| — | Volcano Corp | 44,221 | $470K | 0.1% | $21.84 | — | COM | 928645100 |
| — | Threshold Pharmaceuticals | 121,537 | $439K | 0.1% | $4.67 | — | COM | 885807206 |
| — | Lexicon Pharmaceuticals Inc | 294,805 | $416K | 0.1% | $1.80 | — | COM | 528872104 |
| SRNE | Sorrento Therapeutics Inc | 72,535 | $328K | 0.1% | $9.93 | -45.9% | COM | 83587F202 |
| — | Endocyte Inc | 49,297 | $300K | 0.1% | $19.04 | — | COM | 29269A102 |